BioCentury
ARTICLE | Company News

Northwestern University, Panther Biotechnology deal

April 27, 2015 7:00 AM UTC

Panther exercised a 2014 option to license exclusive, worldwide rights to the university’s numonafide. The preclinical candidate is a small molecule derivative of amonafide, a DNA intercalator and topoisomerase II (TOP2) inhibitor (see BioCentury, Sept. 15, 2014). ...